EIRNABio Platform Technologies: Advancing Translational Biology Research
At EIRNABio, we develop cutting-edge platforms designed to unlock new insights into RNA translation and protein synthesis. Our proprietary platforms empower researchers in biotech and pharma to accelerate discovery, optimize drug development, and gain a deeper understanding of disease mechanisms
Our Proprietary Platforms
EIRNABio Connect
A unique Translatomics data integration and analysis hub enabling non-bioinformaticians to dynamically interrogate and interact with their data and extract meaningful insights.
cMAST
Translon Explorer
A pioneering platform for identifying and characterizing previously overlooked small proteins/peptides, revealing novel therapeutic targets and biological functions.
Our platforms address critical challenges in therapeutic and biomarker discovery – offering scalable, customizable, and highly efficient solutions for identifying new targets, optimizing RNA-based therapeutics, and improving the understanding of gene regulation.
With deep scientific expertise and advanced methodologies, EIRNABio equips researchers with the tools needed to push the boundaries of discovery.
Contact us today to explore how our platform technologies can advance your research.
Explore Partnership / Licensing opportunities!